First Time Loading...

Incyte Corp
NASDAQ:INCY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
NASDAQ:INCY
Watchlist
Price: 57.19 USD 0.16% Market Closed
Updated: May 21, 2024

Incyte Corp
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Incyte Corp
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Incyte Corp
NASDAQ:INCY
Total Other Income
$184.3m
CAGR 3-Years
181%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.5B
CAGR 3-Years
12%
CAGR 5-Years
-62%
CAGR 10-Years
-78%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$158m
CAGR 3-Years
4%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$55.2m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Incyte Corp's Total Other Income?
Total Other Income
184.3m USD

Based on the financial report for Mar 31, 2024, Incyte Corp's Total Other Income amounts to 184.3m USD.

What is Incyte Corp's Total Other Income growth rate?
Total Other Income CAGR 5Y
47%

Over the last year, the Total Other Income growth was 158%. The average annual Total Other Income growth rates for Incyte Corp have been 181% over the past three years , 47% over the past five years .